Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack

Norwegian University of Science and Technology

Status: Completed

Conditions: Ischemic Attack, Transient; Stroke

Treatments: Behavioral: Drug use counselling

Study type: Interventional

Funder types: Other

Identifiers

NCT02089074

2012/1224a

Details and patient eligibility

About

Use of drugs is an important factor in secondary prophylaxis after transient ischemic attack (TIA), but studies show that adherence to the prescribed drugs is often poor. This randomised controlled trial aims to investigate whether a systematic follow up of drug treatment using medication reconciliation, medication reviews and patient counselling by clinical pharmacists, improves adherence and/or decreases cardiovascular events the first three months and the first year after TIA. Patient satisfaction will also be compared between the two groups.

Enrollment: 265 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Probable or possible transient ischemic attack
• Residing in Central Norway
• Examined within 2 weeks after the onset of symptoms
• Modified Rankin Scale 3 or less and living at home
• enrolled in the MIDNOR-TIA study NCT02038725
• Informed consent

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

265 participants in 2 patient groups

drug use counselling

Experimental group

Description:

Pharmacist conducting drug reconciliation, medication reviews and drug use counselling during hospitalisation. Follow up telephone calls 1 week, 1 month, 2 months and three months after discharge from hospital

Treatment:

Behavioral: Drug use counselling

Control group

No Intervention group

Description:

The patients in the control group receive no intervention just treatment and follow up according to national standards